Lv6
1880 积分 2024-06-19 加入
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING
1个月前
已完结
Enhancing the Selectivity of Leucine Aminopeptidase Near-Infrared Fluorescent Probes for Assisting in Surgical Tumor Resection
1个月前
已完结
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap
2个月前
已关闭
Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils
2个月前
已完结
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
5个月前
已完结
Activity of pemetrexed on brain metastases from non-small cell lung cancer: What is the mechanism?
5个月前
已关闭
Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4
6个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
6个月前
已完结
Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer
6个月前
已完结
皖公网安备34019202002308
